Nigeria has fewer than a handful of confirmed tech unicorns — Flutterwave, Interswitch, and OPay among the most cited — and President Bola Tinubu is now publicly targeting health technology as the sector most likely to produce the next crop, according to reporting by Leadership Newspapers, The Nation, and Business News Nigeria.
The push is grounded in a real gap. Nigeria's public health infrastructure serves roughly 220 million people through a system that the World Health Organization has repeatedly rated as severely under-resourced — fewer than 2 physicians per 10,000 people by recent estimates. That structural deficit is precisely what makes digital health a compelling investment thesis: the addressable market is enormous and the incumbent service is weak.
Tinubu's agenda, as reported across the three outlets, frames health tech not merely as a welfare intervention but as an economic development vehicle — a deliberate attempt to replicate the fintech playbook that turned Nigerian payment startups into continent-scale businesses. The government's argument is that the same conditions that made fintech explosive (large unserved population, weak legacy infrastructure, mobile penetration) now apply to healthcare.
Africa's digital health sector attracted roughly $800 million in disclosed venture funding between 2020 and 2023, according to various tracker estimates, with Nigeria, Kenya, South Africa, and Egypt absorbing the largest shares. Nigerian health-tech startups including Helium Health, which has raised over $30 million and operates electronic medical records across hundreds of facilities, and 54gene, the genomics firm that raised $45 million before restructuring, illustrate both the ceiling and the risk. Building durable, revenue-generating businesses in the sector remains harder than raising early-stage capital.
The unicorn framing matters because it sets a specific, measurable target — a $1 billion private valuation — rather than the softer language of digital transformation that often accompanies government tech announcements. Whether or not the Tinubu administration can back that ambition with concrete policy tools is the operative question. What has been reported so far centres on intent: positioning Nigeria as the continent's health-tech hub, creating regulatory conditions for telemedicine and health data exchange, and encouraging foreign direct investment into the sector.
What remains conspicuously absent from the public reporting is the financing architecture. No dedicated fund size, no co-investment vehicle with development finance institutions like the IFC or the African Development Bank, and no specific tax incentive regime for health-tech investors has been announced alongside the rhetoric. For context, Rwanda's health-tech push has been supported by targeted regulatory sandboxes and direct government procurement contracts — tools that created real revenue floors for early-stage companies. Nigeria has not yet signalled equivalent mechanisms.
For investors already active in the space — Novastar Ventures, HealthTech Hub Africa's portfolio backers, or international crossover funds watching the continent — the signal worth tracking is whether this presidential framing translates into procurement. Government as anchor customer has been the single most reliable accelerant for health-tech scale in markets from India to Brazil. A Nigerian government commitment to procure from domestic digital health companies, or to mandate electronic health records across public facilities, would be a structurally more powerful intervention than any grant programme.
Founders operating in the sector should read this moment as a window to engage the policy process directly — standard practice in mature markets but still underdeveloped in Nigeria's startup ecosystem. The National Health Insurance Authority, reformed under a 2022 act, is the most logical procurement lever; startups that can embed their products into the NHIA's claims and provider-management infrastructure will be best positioned if public funding flows.
Why it matters: Presidential attention to a sector moves capital and shapes regulation, but Nigeria's health-tech unicorn ambition will be tested entirely on the specifics — the fund sizes committed, the procurement contracts signed, and the regulatory timelines set — not on the ambition itself.